Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glutaminase | Starlite/ChEMBL | No references |
Homo sapiens | muscleblind-like splicing regulator 1 | Starlite/ChEMBL | No references |
Homo sapiens | RAB9A, member RAS oncogene family | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | Niemann-Pick disease, type C1 | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | glucosidase, alpha | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Plasmodium falciparum | ras-related protein Rab-5B | RAB9A, member RAS oncogene family | 201 aa | 165 aa | 30.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | 0.012 | 0.0674 | 0.1148 |
Brugia malayi | glutaminase DH11.1 | 0.033 | 0.2952 | 0.5593 |
Mycobacterium ulcerans | glutaminase | 0.033 | 0.2952 | 1 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0253 | 0.2113 | 0.6597 |
Echinococcus granulosus | muscleblind protein | 0.018 | 0.1326 | 0.5161 |
Entamoeba histolytica | Niemann-Pick C1 protein, putative | 0.0119 | 0.0659 | 0.5 |
Echinococcus multilocularis | muscleblind protein | 0.018 | 0.1326 | 0.1326 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0103 | 0.0487 | 0.0487 |
Echinococcus multilocularis | geminin | 0.0205 | 0.159 | 0.159 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0197 | 0.1504 | 0.6253 |
Loa Loa (eye worm) | thymidylate synthase | 0.0253 | 0.2113 | 0.4263 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 0.1504 | 0.1504 |
Schistosoma mansoni | glutaminase | 0.033 | 0.2952 | 1 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0356 | 0.3233 | 0.5 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0356 | 0.3233 | 0.5 |
Echinococcus granulosus | geminin | 0.0205 | 0.159 | 0.6779 |
Trichomonas vaginalis | glutaminase, putative | 0.033 | 0.2952 | 1 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.1206 | 0.2918 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0253 | 0.2113 | 1 |
Echinococcus granulosus | thymidylate synthase | 0.0253 | 0.2113 | 1 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 0.1504 | 0.1504 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0356 | 0.3233 | 1 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0356 | 0.3233 | 0.5 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.017 | 0.1213 | 0.4461 |
Loa Loa (eye worm) | hypothetical protein | 0.0119 | 0.0659 | 0.1263 |
Echinococcus multilocularis | expressed conserved protein | 0.0112 | 0.058 | 0.058 |
Brugia malayi | hypothetical protein | 0.0509 | 0.4894 | 1 |
Brugia malayi | hypothetical protein | 0.012 | 0.0674 | 0.0423 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.1206 | 0.2918 |
Echinococcus granulosus | expressed conserved protein | 0.0112 | 0.058 | 0.0573 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.159 | 0.4472 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0197 | 0.1504 | 0.2307 |
Loa Loa (eye worm) | hypothetical protein | 0.0509 | 0.4894 | 1 |
Brugia malayi | thymidylate synthase | 0.0253 | 0.2113 | 0.3689 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.1326 | 0.264 |
Brugia malayi | Niemann-Pick C1 protein precursor | 0.0119 | 0.0659 | 0.0389 |
Mycobacterium ulcerans | thymidylate synthase | 0.0253 | 0.2113 | 0.6597 |
Brugia malayi | Muscleblind-like protein | 0.018 | 0.1326 | 0.1904 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0119 | 0.0659 | 0.0659 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0197 | 0.1504 | 0.3007 |
Echinococcus multilocularis | muscleblind protein 1 | 0.018 | 0.1326 | 0.1326 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0356 | 0.3233 | 0.5 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0121 | 0.0679 | 0.0776 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0356 | 0.3233 | 0.5 |
Loa Loa (eye worm) | glutaminase | 0.033 | 0.2952 | 0.5994 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.159 | 0.4472 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0253 | 0.2113 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.033 | 0.2952 | 0.5994 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0103 | 0.0487 | 0.5 |
Brugia malayi | sulfakinin receptor protein | 0.0509 | 0.4894 | 1 |
Onchocerca volvulus | 0.0253 | 0.2113 | 1 | |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0119 | 0.0659 | 0.1054 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0103 | 0.0487 | 0.0909 |
Echinococcus multilocularis | thymidylate synthase | 0.0253 | 0.2113 | 0.2113 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.017 | 0.1213 | 0.1213 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.1326 | 0.264 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 1.122 um | PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 2.5119 um | PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 3.1623 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 3.2944 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 3.5481 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 4.6109 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 14.575 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (binding) | 17.7828 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 26.8545 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (binding) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.